Jess Branson, of Westport, had a busy career and an active social life. But in the spring of 2021, Branson's life "went from 60 to zero in a heartbeat" when she became unable to move. It all began ...
MONTREAL — An investigational targeted immunotherapy for Guillain-Barré syndrome (GBS) more than doubled improvement in disability after 8 weeks compared with placebo and showed sustained benefit at ...
Singer Sufjan Stevens is on the mend after being diagnosed with the rare autoimmune disorder Guillain-Barré syndrome. The Grammy and Oscar-nominated musician shared an update with his fans on his ...
SAN DIEGO -- A single dose of investigational tanruprubart resulted in rapid, sustained improvement in disability compared with placebo in patients with Guillain-Barré syndrome (GBS), a phase III, ...
Dallas Cowboys All-Pro center Travis Frederick missed the entire 2018 season after being diagnosed with Guillain-Barré Syndrome, a rare autoimmune disease. It was caught in the early stages, Frederick ...
KYOTO, Japan — Eculizumab (Soliris, Alexion Pharmaceuticals) is safe for the treatment of patients with severe Guillain-Barré syndrome (GBS), a new phase 2 study shows. However, although more patients ...
Annexon, Inc. (NASDAQ:ANNX) on Tuesday presented data for its late-stage targeted therapy, tanruprubart (formerly ANX005), for Guillain-Barré Syndrome (GBS). GBS is a neuromuscular emergency affecting ...
A 25-year-old Italian woman has found herself slowly being paralyzed by a rare disease. Initially experiencing back pain, Aurora Mattei's facial muscles and body became paralyzed over the course of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results